APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Grade Poloxamer 407

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pharmaceutical Grade Poloxamer 407 Market Outlook and Growth Opportunities 2026

22 December 2025197 pages

Choose your research edition.

Industry ResearchPharmaceutical Grade Poloxamer 407 Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Grade Poloxamer 407 Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Grade Poloxamer 407 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Grade Poloxamer 407 Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Grade Poloxamer 407 Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Pharmaceutical Grade Poloxamer 407 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pharmaceutical Grade Poloxamer 407 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharmaceutical Grade Poloxamer 407 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmaceutical Grade Poloxamer 407 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pharmaceutical Grade Poloxamer 407 market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pharmaceutical Grade Poloxamer 407 market include BASF, Croda, Comercial Química Massó, CD Formulation and Solvay, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pharmaceutical Grade Poloxamer 407 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmaceutical Grade Poloxamer 407 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmaceutical Grade Poloxamer 407 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pharmaceutical Grade Poloxamer 407 market size, projected growth trends, production technologies, key applications, and end-use industries.

Pharmaceutical Grade Poloxamer 407 Segment by Company

BASF

Croda

Comercial Química Massó

CD Formulation

Solvay

Pharmaceutical Grade Poloxamer 407 Segment by Type

Flakes

Powder

Pharmaceutical Grade Poloxamer 407 Segment by Application

Topical Formulations

Oral Care Formulations

Solid Dosage Forms

Pharmaceutical Grade Poloxamer 407 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pharmaceutical Grade Poloxamer 407 status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Pharmaceutical Grade Poloxamer 407 market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pharmaceutical Grade Poloxamer 407 significant trends, drivers, influence factors in global and regions.

6. To analyze Pharmaceutical Grade Poloxamer 407 competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Grade Poloxamer 407 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Grade Poloxamer 407 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Grade Poloxamer 407.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pharmaceutical Grade Poloxamer 407 market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmaceutical Grade Poloxamer 407 industry.

Chapter 3: Detailed analysis of Pharmaceutical Grade Poloxamer 407 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Pharmaceutical Grade Poloxamer 407 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Pharmaceutical Grade Poloxamer 407 in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pharmaceutical Grade Poloxamer 407 Industry Trends Table 2. Pharmaceutical Grade Poloxamer 407 Industry Drivers Table 3. Pharmaceutical Grade Poloxamer 407 Industry Opportunities and Challenges Table 4. Pharmaceutical Grade Poloxamer 407 Industry Restraints Table 5. Global Pharmaceutical Grade Poloxamer 407 Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pharmaceutical Grade Poloxamer 407 Revenue Share by Company (2021-2026) Table 7. Global Pharmaceutical Grade Poloxamer 407 Sales Volume by Company (Tons) & (2021-2026) Table 8. Global Pharmaceutical Grade Poloxamer 407 Sales Volume Share by Company (2021-2026) Table 9. Global Pharmaceutical Grade Poloxamer 407 Average Price (US$/Ton) of Company (2021-2026) Table 10. Global Pharmaceutical Grade Poloxamer 407 Company Ranking, (2024-2026) & (USD Million) Table 11. Global Pharmaceutical Grade Poloxamer 407 Key Company Manufacturing Base & Headquarters Table 12. Global Pharmaceutical Grade Poloxamer 407 Company, Product Type & Application Table 13. Global Pharmaceutical Grade Poloxamer 407 Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Pharmaceutical Grade Poloxamer 407 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Flakes Table 18. Significant Companies of Powder Table 19. Global Pharmaceutical Grade Poloxamer 407 Sales Volume by Type 2021 VS 2025 VS 2032 (Tons) Table 20. Global Pharmaceutical Grade Poloxamer 407 Sales Volume by Type (2021-2026) & (Tons) Table 21. Global Pharmaceutical Grade Poloxamer 407 Sales Volume by Type (2027-2032) & (Tons) Table 22. Global Pharmaceutical Grade Poloxamer 407 Sales Volume Share by Type (2021-2026) Table 23. Global Pharmaceutical Grade Poloxamer 407 Sales Volume Share by Type (2027-2032) Table 24. Global Pharmaceutical Grade Poloxamer 407 Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Pharmaceutical Grade Poloxamer 407 Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Pharmaceutical Grade Poloxamer 407 Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type (2021-2026) Table 28. Global Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Topical Formulations Table 30. Significant Companies of Oral Care Formulations Table 31. Significant Companies of Solid Dosage Forms Table 32. Global Pharmaceutical Grade Poloxamer 407 Sales Volume by Application 2021 VS 2025 VS 2032 (Tons) Table 33. Global Pharmaceutical Grade Poloxamer 407 Sales Volume by Application (2021-2026) & (Tons) Table 34. Global Pharmaceutical Grade Poloxamer 407 Sales Volume by Application (2027-2032) & (Tons) Table 35. Global Pharmaceutical Grade Poloxamer 407 Sales Volume Share by Application (2021-2026) Table 36. Global Pharmaceutical Grade Poloxamer 407 Sales Volume Share by Application (2027-2032) Table 37. Global Pharmaceutical Grade Poloxamer 407 Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Pharmaceutical Grade Poloxamer 407 Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Pharmaceutical Grade Poloxamer 407 Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application (2021-2026) Table 41. Global Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application (2027-2032) Table 42. Global Pharmaceutical Grade Poloxamer 407 Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 43. Global Pharmaceutical Grade Poloxamer 407 Sales by Region (2021-2026) & (Tons) Table 44. Global Pharmaceutical Grade Poloxamer 407 Sales Market Share by Region (2021-2026) Table 45. Global Pharmaceutical Grade Poloxamer 407 Sales by Region (2027-2032) & (Tons) Table 46. Global Pharmaceutical Grade Poloxamer 407 Sales Market Share by Region (2027-2032) Table 47. Global Pharmaceutical Grade Poloxamer 407 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Pharmaceutical Grade Poloxamer 407 Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Pharmaceutical Grade Poloxamer 407 Sales Value Share by Region (2021-2026) Table 50. Global Pharmaceutical Grade Poloxamer 407 Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Pharmaceutical Grade Poloxamer 407 Sales Value Share by Region (2027-2032) Table 52. Global Pharmaceutical Grade Poloxamer 407 Market Average Price (US$/Ton) by Region (2021-2026) Table 53. Global Pharmaceutical Grade Poloxamer 407 Market Average Price (US$/Ton) by Region (2027-2032) Table 54. Global Pharmaceutical Grade Poloxamer 407 Sales by Country: 2021 VS 2025 VS 2032 (Tons) Table 55. Global Pharmaceutical Grade Poloxamer 407 Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Pharmaceutical Grade Poloxamer 407 Sales by Country (2021-2026) & (Tons) Table 57. Global Pharmaceutical Grade Poloxamer 407 Sales Market Share by Country (2021-2026) Table 58. Global Pharmaceutical Grade Poloxamer 407 Sales by Country (2027-2032) & (Tons) Table 59. Global Pharmaceutical Grade Poloxamer 407 Sales Market Share by Country (2027-2032) Table 60. Global Pharmaceutical Grade Poloxamer 407 Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Pharmaceutical Grade Poloxamer 407 Sales Value Market Share by Country (2021-2026) Table 62. Global Pharmaceutical Grade Poloxamer 407 Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Pharmaceutical Grade Poloxamer 407 Sales Value Market Share by Country (2027-2032) Table 64. BASF Company Information Table 65. BASF Business Overview Table 66. BASF Pharmaceutical Grade Poloxamer 407 Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 67. BASF Pharmaceutical Grade Poloxamer 407 Product Portfolio Table 68. BASF Recent Development Table 69. Croda Company Information Table 70. Croda Business Overview Table 71. Croda Pharmaceutical Grade Poloxamer 407 Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 72. Croda Pharmaceutical Grade Poloxamer 407 Product Portfolio Table 73. Croda Recent Development Table 74. Comercial Química Massó Company Information Table 75. Comercial Química Massó Business Overview Table 76. Comercial Química Massó Pharmaceutical Grade Poloxamer 407 Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 77. Comercial Química Massó Pharmaceutical Grade Poloxamer 407 Product Portfolio Table 78. Comercial Química Massó Recent Development Table 79. CD Formulation Company Information Table 80. CD Formulation Business Overview Table 81. CD Formulation Pharmaceutical Grade Poloxamer 407 Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 82. CD Formulation Pharmaceutical Grade Poloxamer 407 Product Portfolio Table 83. CD Formulation Recent Development Table 84. Solvay Company Information Table 85. Solvay Business Overview Table 86. Solvay Pharmaceutical Grade Poloxamer 407 Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 87. Solvay Pharmaceutical Grade Poloxamer 407 Product Portfolio Table 88. Solvay Recent Development Table 89. Key Raw Materials Table 90. Raw Materials Key Suppliers Table 91. Pharmaceutical Grade Poloxamer 407 Distributors List Table 92. Pharmaceutical Grade Poloxamer 407 Customers List Table 93. Research Programs/Design for This Report Table 94. Authors List of This Report Table 95. Secondary Sources Table 96. Primary Sources List of Figures Figure 1. Pharmaceutical Grade Poloxamer 407 Product Image Figure 2. Global Pharmaceutical Grade Poloxamer 407 Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceutical Grade Poloxamer 407 Sales Value (2021-2032) & (US$ Million) Figure 4. Global Pharmaceutical Grade Poloxamer 407 Sales (2021-2032) & (Tons) Figure 5. Global Pharmaceutical Grade Poloxamer 407 Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global Pharmaceutical Grade Poloxamer 407 Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Flakes Image Figure 10. Powder Image Figure 11. Global Pharmaceutical Grade Poloxamer 407 Sales Volume by Type (2021 VS 2025 VS 2032) & (Tons) Figure 12. Global Pharmaceutical Grade Poloxamer 407 Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Pharmaceutical Grade Poloxamer 407 Sales Volume Share by Type (2021-2032) Figure 14. Global Pharmaceutical Grade Poloxamer 407 Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Pharmaceutical Grade Poloxamer 407 Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type (2021-2032) Figure 17. Topical Formulations Image Figure 18. Oral Care Formulations Image Figure 19. Solid Dosage Forms Image Figure 20. Global Pharmaceutical Grade Poloxamer 407 Sales Volume by Application (2021 VS 2025 VS 2032) & (Tons) Figure 21. Global Pharmaceutical Grade Poloxamer 407 Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Pharmaceutical Grade Poloxamer 407 Sales Volume Share by Application (2021-2032) Figure 23. Global Pharmaceutical Grade Poloxamer 407 Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Pharmaceutical Grade Poloxamer 407 Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application (2021-2032) Figure 26. Global Pharmaceutical Grade Poloxamer 407 Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 27. Global Pharmaceutical Grade Poloxamer 407 Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Pharmaceutical Grade Poloxamer 407 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Pharmaceutical Grade Poloxamer 407 Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Pharmaceutical Grade Poloxamer 407 Sales Value (2021-2032) & (US$ Million) Figure 31. North America Pharmaceutical Grade Poloxamer 407 Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Pharmaceutical Grade Poloxamer 407 Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Pharmaceutical Grade Poloxamer 407 Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Pharmaceutical Grade Poloxamer 407 Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Pharmaceutical Grade Poloxamer 407 Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Pharmaceutical Grade Poloxamer 407 Sales Value (2021-2032) & (US$ Million) Figure 37. South America Pharmaceutical Grade Poloxamer 407 Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Pharmaceutical Grade Poloxamer 407 Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Pharmaceutical Grade Poloxamer 407 Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Pharmaceutical Grade Poloxamer 407 Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Pharmaceutical Grade Poloxamer 407 Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Flakes
  • Powder
Applications
  • Topical Formulations
  • Oral Care Formulations
  • Solid Dosage Forms
Companies covered
  • BASF
  • Croda
  • Comercial Química Massó
  • CD Formulation
  • Solvay

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pharmaceutical Grade Poloxamer 407 Sales Value (2021-2032)
  4. 1.2.2 Global Pharmaceutical Grade Poloxamer 407 Sales Volume (2021-2032)
  5. 1.2.3 Global Pharmaceutical Grade Poloxamer 407 Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Pharmaceutical Grade Poloxamer 407 Market Dynamics
  1. 2.1 Pharmaceutical Grade Poloxamer 407 Industry Trends
  2. 2.2 Pharmaceutical Grade Poloxamer 407 Industry Drivers
  3. 2.3 Pharmaceutical Grade Poloxamer 407 Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical Grade Poloxamer 407 Industry Restraints
3 Pharmaceutical Grade Poloxamer 407 Market by Company
  1. 3.1 Global Pharmaceutical Grade Poloxamer 407 Company Revenue Ranking in 2025
  2. 3.2 Global Pharmaceutical Grade Poloxamer 407 Revenue by Company (2021-2026)
  3. 3.3 Global Pharmaceutical Grade Poloxamer 407 Sales Volume by Company (2021-2026)
  4. 3.4 Global Pharmaceutical Grade Poloxamer 407 Average Price by Company (2021-2026)
  5. 3.5 Global Pharmaceutical Grade Poloxamer 407 Company Ranking (2024-2026)
  6. 3.6 Global Pharmaceutical Grade Poloxamer 407 Company Manufacturing Base and Headquarters
  7. 3.7 Global Pharmaceutical Grade Poloxamer 407 Company Product Type and Application
  8. 3.8 Global Pharmaceutical Grade Poloxamer 407 Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Pharmaceutical Grade Poloxamer 407 Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Pharmaceutical Grade Poloxamer 407 Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Pharmaceutical Grade Poloxamer 407 Market by Type
  1. 4.1 Pharmaceutical Grade Poloxamer 407 Type Introduction
  2. 4.1.1 Flakes
  3. 4.1.2 Powder
  4. 4.2 Global Pharmaceutical Grade Poloxamer 407 Sales Volume by Type
  5. 4.2.1 Global Pharmaceutical Grade Poloxamer 407 Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Pharmaceutical Grade Poloxamer 407 Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Pharmaceutical Grade Poloxamer 407 Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Pharmaceutical Grade Poloxamer 407 Sales Value by Type
  9. 4.3.1 Global Pharmaceutical Grade Poloxamer 407 Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Pharmaceutical Grade Poloxamer 407 Sales Value by Type (2021-2032)
  11. 4.3.3 Global Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type (2021-2032)
5 Pharmaceutical Grade Poloxamer 407 Market by Application
  1. 5.1 Pharmaceutical Grade Poloxamer 407 Application Introduction
  2. 5.1.1 Topical Formulations
  3. 5.1.2 Oral Care Formulations
  4. 5.1.3 Solid Dosage Forms
  5. 5.2 Global Pharmaceutical Grade Poloxamer 407 Sales Volume by Application
  6. 5.2.1 Global Pharmaceutical Grade Poloxamer 407 Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pharmaceutical Grade Poloxamer 407 Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Pharmaceutical Grade Poloxamer 407 Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Pharmaceutical Grade Poloxamer 407 Sales Value by Application
  10. 5.3.1 Global Pharmaceutical Grade Poloxamer 407 Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Pharmaceutical Grade Poloxamer 407 Sales Value by Application (2021-2032)
  12. 5.3.3 Global Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application (2021-2032)
6 Pharmaceutical Grade Poloxamer 407 Regional Sales and Value Analysis
  1. 6.1 Global Pharmaceutical Grade Poloxamer 407 Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pharmaceutical Grade Poloxamer 407 Sales by Region (2021-2032)
  3. 6.2.1 Global Pharmaceutical Grade Poloxamer 407 Sales by Region: 2021-2026
  4. 6.2.2 Global Pharmaceutical Grade Poloxamer 407 Sales by Region (2027-2032)
  5. 6.3 Global Pharmaceutical Grade Poloxamer 407 Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Pharmaceutical Grade Poloxamer 407 Sales Value by Region (2021-2032)
  7. 6.4.1 Global Pharmaceutical Grade Poloxamer 407 Sales Value by Region: 2021-2026
  8. 6.4.2 Global Pharmaceutical Grade Poloxamer 407 Sales Value by Region (2027-2032)
  9. 6.5 Global Pharmaceutical Grade Poloxamer 407 Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Pharmaceutical Grade Poloxamer 407 Sales Value (2021-2032)
  12. 6.6.2 North America Pharmaceutical Grade Poloxamer 407 Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Pharmaceutical Grade Poloxamer 407 Sales Value (2021-2032)
  15. 6.7.2 Europe Pharmaceutical Grade Poloxamer 407 Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Pharmaceutical Grade Poloxamer 407 Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Pharmaceutical Grade Poloxamer 407 Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Pharmaceutical Grade Poloxamer 407 Sales Value (2021-2032)
  21. 6.9.2 South America Pharmaceutical Grade Poloxamer 407 Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Pharmaceutical Grade Poloxamer 407 Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Pharmaceutical Grade Poloxamer 407 Sales Value Share by Country, 2025 VS 2032
7 Pharmaceutical Grade Poloxamer 407 Country-level Sales and Value Analysis
  1. 7.1 Global Pharmaceutical Grade Poloxamer 407 Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pharmaceutical Grade Poloxamer 407 Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Pharmaceutical Grade Poloxamer 407 Sales by Country (2021-2032)
  4. 7.3.1 Global Pharmaceutical Grade Poloxamer 407 Sales by Country (2021-2026)
  5. 7.3.2 Global Pharmaceutical Grade Poloxamer 407 Sales by Country (2027-2032)
  6. 7.4 Global Pharmaceutical Grade Poloxamer 407 Sales Value by Country (2021-2032)
  7. 7.4.1 Global Pharmaceutical Grade Poloxamer 407 Sales Value by Country (2021-2026)
  8. 7.4.2 Global Pharmaceutical Grade Poloxamer 407 Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Pharmaceutical Grade Poloxamer 407 Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Pharmaceutical Grade Poloxamer 407 Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Pharmaceutical Grade Poloxamer 407 Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 BASF
  2. 8.1.1 BASF Company Information
  3. 8.1.2 BASF Business Overview
  4. 8.1.3 BASF Pharmaceutical Grade Poloxamer 407 Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 BASF Pharmaceutical Grade Poloxamer 407 Product Portfolio
  6. 8.1.5 BASF Recent Developments
  7. 8.2 Croda
  8. 8.2.1 Croda Company Information
  9. 8.2.2 Croda Business Overview
  10. 8.2.3 Croda Pharmaceutical Grade Poloxamer 407 Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Croda Pharmaceutical Grade Poloxamer 407 Product Portfolio
  12. 8.2.5 Croda Recent Developments
  13. 8.3 Comercial Química Massó
  14. 8.3.1 Comercial Química Massó Company Information
  15. 8.3.2 Comercial Química Massó Business Overview
  16. 8.3.3 Comercial Química Massó Pharmaceutical Grade Poloxamer 407 Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Comercial Química Massó Pharmaceutical Grade Poloxamer 407 Product Portfolio
  18. 8.3.5 Comercial Química Massó Recent Developments
  19. 8.4 CD Formulation
  20. 8.4.1 CD Formulation Company Information
  21. 8.4.2 CD Formulation Business Overview
  22. 8.4.3 CD Formulation Pharmaceutical Grade Poloxamer 407 Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 CD Formulation Pharmaceutical Grade Poloxamer 407 Product Portfolio
  24. 8.4.5 CD Formulation Recent Developments
  25. 8.5 Solvay
  26. 8.5.1 Solvay Company Information
  27. 8.5.2 Solvay Business Overview
  28. 8.5.3 Solvay Pharmaceutical Grade Poloxamer 407 Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Solvay Pharmaceutical Grade Poloxamer 407 Product Portfolio
  30. 8.5.5 Solvay Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pharmaceutical Grade Poloxamer 407 Value Chain Analysis
  2. 9.1.1 Pharmaceutical Grade Poloxamer 407 Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pharmaceutical Grade Poloxamer 407 Sales Mode & Process
  6. 9.2 Pharmaceutical Grade Poloxamer 407 Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pharmaceutical Grade Poloxamer 407 Distributors
  9. 9.2.3 Pharmaceutical Grade Poloxamer 407 Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst